IP Library Granted Patent US 7,939,264
Granted Patent B1
US 7,939,264 · App. 12/710,059 · Granted May 10, 2011

DNA sequencing method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,939,264
App. No.
12/710,059
Granted
May 10, 2011
Kind
B1
Abstract

The present invention pertains to a method for determining the sequence of a polynucleotide, the method relying on the detection of a conformational change in an enzyme that interacts with and processes along the polynucleotide. The detection of a conformational change may be carried out by measuring changes in a fluorophore bound to the enzyme.

Claims (27)

1. A method for determining the sequence of a polynucleotide, comprising the steps

(i) contacting a target polynucleotide with a polynucleotide processive enzyme, wherein the enzyme comprises a first type and second type of interactive label, and the degree of interaction between the first and second type of label is dependent on a conformational change in the enzyme; and

(ii) detecting conformational changes in the enzyme as the enzyme processes along the polynucleotide, thereby determining the sequence of the polynucleotide.

2. The method according to claim 1 , wherein the enzyme is a polymerase enzyme.

3. The method according to claim 1 , wherein the enzyme is a helicase enzyme or a primase enzyme.

4. The method according to claim 1 , wherein the enzyme is immobilized on a solid support.

5. The method according to claim 4 , comprising a plurality of enzymes immobilized on the solid support.

6. The method according to claim 1 , wherein the characteristics of the first type of label alter as the enzyme undergoes a conformational change.

7. The method according to claim 1 , wherein the first type of label is an energy acceptor and the second type of label is an energy donor, or wherein the first type of label is an energy donor and the second type of label is an energy acceptor, and wherein the detection step is carried out by measuring energy transfer between the two types of labels.

8. The method according to claim 1 , wherein the detection step is carried out using confocal microscopy.

9. The method according to claim 8 , wherein the detection step is carried out by fluorescence imaging.

10. The method according to claim 6 , wherein the detection step is carried out by measuring a polarisation effect consequent on the altered characteristics of the first label.

11. The method according to claim 10 , wherein the detection step is carried out by fluorescence polarisation anisotrophy.

12. The method according to claim 2 , wherein the conformational change is brought about when the polymerase incorporates a nucleotide into a nascent strand complementary to the target polynucleotide.

13. The method according to claim 12 , wherein the nascent strand is a primer sequence.

14. The method according to claim 12 , wherein the detecting step occurs in a flow cell.

15. The method according to claim 1 , wherein the enzyme forms a complex with the target polynucleotide, and the detecting step is repeated one or more times utilizing the same complex.

16. The method according to claim 15 , wherein the contacting and/or detecting step occur under conditions sufficient to induce enzyme activity.

17. A method for determining the sequence of a polynucleotide, comprising the steps of:

(i) contacting a polymerase enzyme with an unlabeled target polynucleotide to form a complex;

(ii) contacting the complex with one or more unlabeled nucleoside triphosphates selected from the group consisting of dATP, dTTP, dGTP, and dCTP, under conditions sufficient to induce polymerase activity; and

(iii) detecting a change in pH as the enzyme processes along the target polynucleotide, thereby determining the sequence of the target polynucleotide, wherein the pH change results from the incorporation of a nucleoside triphosphate into a nascent nucleotide strand complementary to the target polynucleotide.

18. The method according to claim 17 , wherein the enzyme comprises a fusion of green fluorescent protein to the enzyme.

19. The method according to claim 17 , wherein steps (ii) and (iii) are repeated one or more times utilizing the same complex.

20. The method according to claim 17 , wherein the nascent strand is a primer sequence.

21. The method according to claim 17 , wherein the detecting step occurs in a flow cell.

22. The method according to claim 17 , wherein the enzyme and/or the complex is immobilized on a solid support.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: MEDICAL BIOSYSTEMS LIMITED
To: REJUVIGEN LIMITED
Reel/Frame 024896/0283 →
CHANGE OF NAME Recorded Aug 27, 2010
From: REJUVIGEN LIMITED
To: MOBIOUS BIOSYSTEMS LIMITED
Reel/Frame 024896/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: MOBIOUS BIO SYSTEMS LIMITED
To: GEN-PROBE INCORPORATED
Reel/Frame 024896/0309 →